Changing Of The Seasonale: Barr’s Extended-Cycle Contraceptive Goes Generic
This article was originally published in The Pink Sheet Daily
Executive Summary
Company tries to hedge losses through “authorized” generic and follow-on Seasonique.
You may also be interested in...
Barr Seeks FDA Approval Of Low-Dose Extended-Cycle Contraceptive Lo Seasonique
FDA grants Lo Seasonique an Oct. 24 action date.
Barr Seeks FDA Approval Of Low-Dose Extended-Cycle Contraceptive Lo Seasonique
FDA grants Lo Seasonique an Oct. 24 action date.
Barr Seasonique DTC Campaign Producing Results, Firm Says
Direct-to-consumer ads launched in July are driving consumer inquiries to physicians.